 |
|
Questions Concerning the Randomized Trial of Schema-Focused Therapy vs Transference-Focused Psychotherapy—Reply
Josephine Giesen-Bloo, PhD;
Arnoud Arntz, PhD
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
In reply
With this response we want to clarify and, for the most, refute the issues raised by Dr Yeomans.
The role of Dr Yeomans as a consultant was described in the article.1(pp650-651) If Dr Yeomans means that he was not responsible for the individual treatments, he is correct; he was not a supervisor in that sense.
"Recent suicidality" and "parasuicidality," both based on several items within 1 Borderline Personality Disorder Severity Index, fourth version (BPDSI-IV), subscale, did not significantly influence dropout (P>.20). If anything, suicidality was related to completing treatment (odds ratio = 1.7).
The gold standard nowadays is intention-to-treat analysis because, among other reasons, completers analysis might be biased in 2 respects. First, general outcome may be inflated when dropouts are not taken into account, if dropouts are dominated by patients who did not profit from treatment. This is usually the case, . . . [Full Text of this Article]
AUTHOR INFORMATION
RELATED LETTER
Questions Concerning the Randomized Trial of Schema-Focused Therapy vs Transference-Focused Psychotherapy
Frank Yeomans
Arch Gen Psychiatry. 2007;64(5):609-610.
EXTRACT
| FULL TEXT
RELATED ARTICLE
Outpatient Psychotherapy for Borderline Personality Disorder: Randomized Trial of Schema-Focused Therapy vs Transference-Focused Psychotherapy
Josephine Giesen-Bloo, Richard van Dyck, Philip Spinhoven, Willem van Tilburg, Carmen Dirksen, Thea van Asselt, Ismay Kremers, Marjon Nadort, and Arnoud Arntz
Arch Gen Psychiatry. 2006;63(6):649-658.
ABSTRACT
| FULL TEXT
|
